long intergenic non-protein coding RNA 886Genealiases: []
Q-omics provides the consensus-scored LINC00886 profile across patient tissues and cancer cell-line models. LINC00886 expression is associated with patient survival in 23 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, LINC00886 is differentially expressed in 15, with the highest sampling consensus in KIRC. Additionally, LINC00886 RNA expression shows 17,110 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight KIRC, and UVM as cancer lineages where LINC00886 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC00886 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC00886 survival associations across molecular data types. LINC00886 RNA expression shows survival associations in the most cancer types (23), followed by mutation status (3). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC00886 RNA expression–survival associations across cancer types. High LINC00886 expression shows unfavorable associations in LGG, but favorable associations in KIRC, KIRP, MESO, BLCA and ACC. The KIRC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for LINC00886 RNA expression.
This table summarizes LINC00886 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 15. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC00886. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC00886 shows lower tumor expression in KIRC, THCA, KIRP, LUSC and UCEC and higher tumor expression in LIHC. The KIRC box plot shows higher LINC00886 RNA expression in normal versus tumor tissue (log2 FC = −0.686, t-test p < 0.001).
This table shows molecular features associated with LINC00886 in patient tissues and cancer cell lines. In patient samples, LINC00886 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
